Turkiye Klinikleri Journal of Internal Medicine

.: REVIEW
Diyabet Yönetiminde Teknoloji Kullanımı
Usage of Technology in the Management of Diabetes
Dilek BÜYÜKKAYA BESENa, Merve DERVİŞOĞLUb
aDokuz Eylül Üniversitesi Hemşirelik Fakültesi, İç Hastalıkları Hemşireliği ABD, İzmir, TÜRKİYE
bDokuz Eylül Üniversitesi Sağlık Bilimleri Enstitüsü, İç Hastalıkları Hemşireliği Yüksek Lisans Programı, İzmir, TÜRKİYE
Turkiye Klinikleri J Intern Med. 2021;6(2):80-5
doi: 10.5336/intermed.2020-77581
Article Language: TR
Full Text
ÖZET
 Bilim ve teknolojideki ilerlemeler, kronik hastalıkların yönetimini ve kontrolünü kolaylaştırırken, bireylerin hastalık yönetiminde güçlenmesine olanak sağlamaktadır. Diyabetli bireylerin öz yönetimlerini artırmak ve güçlendirmek için bilişim teknolojileriyle desteklenmeleri önemlidir. Son yıllarda diyabet teknolojisi hızla gelişmiş ve yeni teknolojiler geliştirilmiştir. Bu geliştirilen teknolojiler; diyabetin etkin yönetimine, bireylerin yaşam kalitesinin artırılmasına ve hastalığın neden olduğu fiziksel, psikolojik, sosyal yüklerin azalmasına katkı sağlamıştır. Diyabetteki teknolojik ilerlemelerin temeli, sürekli deri altı insülin infüzyonu (CSII veya insülin pompası) ve sürekli glikoz izleme [continuous glucose monitoring (CGM)] sistemlerinin geliştirilmesi üzerinedir. CGM cihazları, implante edilebilir subkütan CGM sistemi, insülin pompası, insülin portu, hipoglisemi uyarı bilekliği, nazal glukagon gibi ürünler, diyabet teknolojisi içinde yer almaktadır. Bu cihazlara ek olarak, noninvaziv glikoz ölçümü sağlayabileceği düşünülen mikroinvaziv yama, hidrojel dövme, terden (gözlük ve bileklik) glikoz ölçümü, tükürükten glikoz ölçümü yapan biyosensörler, diş aksesuarları ve akıllı kontak lens ile glikoz ölçüm yöntemleri üzerine çalışmalar hâlâ devam etmektedir. Diyabet yönetiminde kullanılan ve üzerinde çalışmaların devam ettiği bu teknolojik gelişmeler, bireyin hastalığı üzerindeki kontrolünü, yaşam kalitesini ve konforunu artırmayı hedeflemektedir. Sağlık profesyonellerinin, teknolojik gelişmeler konusunda bilgi ve fikir sahibi olması, eğitim, danışmanlık rollerini yerine getirmesinde önemlidir. Ayrıca bu konudaki okumalar, çözümler için yeni fikirlere, kullanılan teknolojik ürünlerin özelliklerinin geliştirilmesine ya da farklı ürünlerin ortaya çıkarılmasına altyapı sağlayabilir.

Anahtar Kelimeler: Diyabet; diyabet yönetimi; teknoloji
ABSTRACT
 Progresses in science and technology facilitate the management and control of chronic diseases, while enabling individuals to become stronger in disease management. It is important that individuals with diabetes are supported with information technologies to improve and strengthen their self-management. In recent years, diabetes technology improved rapidly, and new technologies were developed. These recently developed technologies have contributed to the effective management of diabetes, improving the quality of life of individuals and reducing physical, psychological and social burdens caused by the disease. Technological advances in diabetes arebased on the development of continuous subcutaneous insulin infusion (CSII or insulin pump) and continuous glucose monitoring (CGM) systems. Diabetes technology includes products such as CGM devices, implantable subcutaneous CGM system, insulin pump, insulin port, hypoglycemia stimulation wristband and nasal glucagon. In addition to these devices, studies are still ongoing on microinvasive patch, hydrogel tattoo, glucose measurement from sweat (glasses and wristband), biosensors measuring glucose from saliva, dental accessories and glucose measurement methods by smart contact lens, which are thought to allow for noninvasive glucose measurement. These technological advancements used in management of diabetes, which involve ongoing studies, aim to increase individuals control over the disease, their quality of life and comfort. It is important for health professionals to have knowledge and insight about technological advancements in fulfilling their training and consultancy roles. In addition, readings on this subject can provide infrastructure for new ideas for solutions, improvements of the features of the technological products used or discovery of different products.

Keywords: Diabetes; diabetes management; technology
REFERENCES:
  1. World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. (Erişim Tarihi: 15.07.2020) [Link] 
  2. Bloom DE, Chen S, McGovern ME. The economic burden of noncommunicable diseases and mental health conditions: results for Costa Rica, Jamaica, and Peru. Rev Panam Salud Publica. 2018;42:e18. [Crossref]  [PubMed]  [PMC] 
  3. Taylor CB, Miller NH, Reilly KR, Greenwald G, Cunning D, Deeter A, et al. Evaluation of a nurse-care management system to improve outcomes in patients with complicated diabetes. Diabetes Care. 2003;26(4):1058-63. [Crossref]  [PubMed] 
  4. Özdemir Ü, Taşcı S. [Psychosocial problems and care in chronic diseases]. ERÜ Sağlık Bilimleri Fakültesi Dergisi. 2013;1(1):57-72. [Link] 
  5. Yıldırım JG, Çevirgen A. [Information technologies applications in the management of chronic diseases]. CBU-SBED. 2019;6(1):65-73. [Link] 
  6. Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel JP, et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387(10033):2145-54. [Crossref]  [PubMed]  [PMC] 
  7. Golics CJ, Basra MK, Salek MS, Finlay AY. The impact of patients' chronic disease on family quality of life: an experience from 26 specialties. Int J Gen Med. 2013;6:787-98. [Crossref]  [PubMed]  [PMC] 
  8. The World Health Organisation. Global Health Observatory data. NCD Mortality and morbidity reportaccessed at (Erişim Tarihi: 28.05.2020) [Link] 
  9. Karakoç Kumsar A, Taşkın Yılmaz F. [Overview of quality of life in chronic disease patients]. ERÜ Sağlık Bilimleri Fakültesi Dergisi. 2014;2(2): 62-70. [Link] 
  10. Jeon YH, Essue B, Jan S, Wells R, Whitworth JA. Economic hardship associated with managing chronic illness: a qualitative inquiry. BMC Health Serv Res. 2009;9:182. [Crossref]  [PubMed]  [PMC] 
  11. Morsanutto A, Berto P, Lopatriello S, Gelisio R, Voinovich D, Cippo PP, et al. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis. J Diabetes Complications. 2006;20(3):163-9. [Crossref]  [PubMed] 
  12. Coşansu G. [Diabetes: a global epidemic disease]. Okmeydanı Tıp Dergisi. 2015;31:1-6. [Link] 
  13. American Diabetes Association. 2. classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41 (Suppl 1):13-27. [Crossref]  [PubMed] 
  14. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. [Crossref]  [PubMed] 
  15. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1(1):2-4. [PubMed] 
  16. Yüksel M, Bektaş H. [Current approaches in the administration of chronic complications related to diabetes]. Turkiye Klinikleri J Nurs Sci. 2020;12(1):133-57. [Crossref] 
  17. Jordan RE, Majothi S, Heneghan NR, Blissett DB, Riley RD, Sitch AJ, et al. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis. Health Technol Assess. 2015;19(36):1-516. [Crossref]  [PubMed]  [PMC] 
  18. Panagioti M, Richardson G, Small N, Murray E, Rogers A, Kennedy A, et al. Self-management support interventions to reduce health care utilisation without compromising outcomes: a systematic review and meta-analysis. BMC Health Serv Res. 2014;14:356. [Crossref]  [PubMed]  [PMC] 
  19. Walker RC, Tong A, Howard K, Palmer SC. Patient expectations and experiences of remote monitoring for chronic diseases: Systematic review and thematic synthesis of qualitative studies. Int J Med Inform. 2019;124:78-85. [Crossref]  [PubMed] 
  20. Peters AL, Ahmann AJ, Battelino T, Evert A, Hirsch IB, Murad MH, et al. Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3922-37. [Crossref]  [PubMed] 
  21. Heinemann L. Future of diabetes technology. J Diabetes Sci Technol. 2017;11(5):863-9. [Crossref]  [PubMed]  [PMC] 
  22. T.C. Sağlık Bakanlığı. [Turkey NCD multi-stakeholder action plan 2017-2025]. Erişim Tarihi: 28.05.2020. [Link] 
  23. Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clinical Diabetes. 2004;22(3):123-7. [Crossref] 
  24. Umpierrez GE, Klonoff DC. Diabetes Technology update: use of ınsulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41(8):1579-89. [Crossref]  [PubMed]  [PMC] 
  25. Ginsberg BH. Factors affecting blood glucose monitoring: sources of errors in measurement. J Diabetes Sci Technol. 2009;3(4):903-13. [Crossref]  [PubMed]  [PMC] 
  26. Lansang MC, Modic MB, Sauvey R, Lock P, Ross D, Combs P, et al. Approach to the adult hospitalized patient on an insulin pump. J Hosp Med. 2013;8(12):721-7. [Crossref]  [PubMed] 
  27. Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care. 2015;38(4):716-22. [Crossref]  [PubMed] 
  28. Forlenza GP, Buckingham B, Maahs DM. Progress in diabetes technology: developments in insulin pumps, continuous glucose monitors, and progress towards the artificial pancreas. J Pediatr. 2016;169:13-20. [Crossref]  [PubMed]  [PMC] 
  29. Ajjan RA. How can we realize the clinical benefits of continuous glucose monitoring? Diabetes Technol Ther. 2017;19(S2):S27-S36. [Crossref]  [PubMed]  [PMC] 
  30. Klonoff DC, Ahn D, Drincic A. Continuous glucose monitoring: A review of the technology and clinical use. Diabetes Res Clin Pract. 2017;133:178-92. [Crossref]  [PubMed] 
  31. Vashist SK. Continuous glucose monitoring systems: a review. Diagnostics (Basel). 2013;3(4):385-412. [Crossref]  [PubMed]  [PMC] 
  32. Hirsch IB, Armstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL, et al. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther. 2008;10(4):232-44; quiz 245-6. [Crossref]  [PubMed] 
  33. Polonsky WH, Hessler D. What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users. Diabetes Technol Ther. 2013;15(4):295-301. [Crossref]  [PubMed] 
  34. Tanenbaum ML, Hanes SJ, Miller KM, Naranjo D, Bensen R, Hood KK. Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets. Diabetes Care. 2017;40(2):181-7. [Crossref]  [PubMed]  [PMC] 
  35. Tansey M, Laffel L, Cheng J, Beck R, Coffey J, Huang E, et al; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabet Med. 2011;28(9):1118-22. [Crossref]  [PubMed] 
  36. Cemeroglu AP, Stone R, Kleis L, Racine MS, Postellon DC, Wood MA. Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit. Pediatr Diabetes. 2010;11(3):182-7. [Crossref]  [PubMed] 
  37. Christiansen MP, Klaff LJ, Bailey TS, Brazg R, Carlson G, Tweden KS. A prospective multicenter evaluation of the accuracy and safety of an implanted continuous glucose sensor: The PRECISION study. Diabetes Technology & Therapeutics. 2019;21(5):231-7. [Crossref]  [PubMed]  [PMC] 
  38. Christiansen MP, Klaff LJ, Brazg R, Chang AR, Levy CJ, Lam D, et al. A prospective multicenter evaluation of the accuracy of a novel ımplanted continuous glucose sensor: PRECISE II. Diabetes Technol Ther. 2018;20(3):197-206. [Crossref]  [PubMed]  [PMC] 
  39. Dehennis A, Mortellaro MA, Ioacara S. Multisite study of an ımplanted continuous glucose sensor over 90 days in patients with diabetes Mellitus. J Diabetes Sci Technol. 2015;9(5):951-6. [Crossref]  [PubMed]  [PMC] 
  40. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care. 1999;22(11):1779-84. [Crossref]  [PubMed] 
  41. Berthe E, Lireux B, Coffin C, Goulet-Salmon B, Houlbert D, Boutreux S, et al. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res. 2007;39(3):224-9. [Crossref]  [PubMed] 
  42. Ghazanfar H, Rizvi SW, Khurram A, Orooj F, Qaiser I. Impact of insulin pump on quality of life of diabetic patients. Indian J Endocrinol Metab. 2016;20(4):506-11. [Crossref]  [PubMed]  [PMC] 
  43. Didangelos T, Iliadis F. Insulin pump therapy in adults. Diabetes Res Clin Pract. 2011;93 Suppl 1:S109-13. [Crossref]  [PubMed] 
  44. Aleppo G, Webb KM. Integrated insulin pump and continuous glucose monitoring technology in diabetes care today: a perspective of real-life experience with the MINIMED? 670g hybrid closed-loop system. Endocr Pract. 2018;24(7):684-92. [Crossref]  [PubMed] 
  45. Faulds ER, Zappe J, Dungan KM. Real-world implications of hybrid close loop (hcl) insulin delivery system. Endocr Pract. 2019;25(5):477-84. [Crossref]  [PubMed]  [PMC] 
  46. Knebel T, Neumiller JJ. Medtronic MiniMed 670G hybrid closed-loop system. Clin Diabetes. 2019;37(1):94-5. [Crossref]  [PubMed]  [PMC] 
  47. Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, et al. Glucose outcomes with the in-home use of a hybrid closed-loop ınsulin delivery system in adolescents and adults with Type 1 diabetes. Diabetes Technol Ther. 2017;19(3):155-63. [Crossref]  [PubMed]  [PMC] 
  48. Medtronic [Internet]. © 2020 Medtronic [cited 29.5.2020]. İ-Port Advance. Available from: [Link] 
  49. Hypoband [Internet]. © 2020, Hypoband [cited 29.5.2020]. Why Hypoband. Available from: (Erişim:29.05.2020) [Link] 
  50. Pöhlmann J, Mitchell BD, Bajpai S, Osumili B, Valentine WJ. Nasal glucagon versus injectable glucagon for severe hypoglycemia: a cost-offset and budget impact analysis. J Diabetes Sci Technol. 2019;13(5):910-8. [Crossref]  [PubMed]  [PMC] 
  51. Kedia N. Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach. Diabetes Metab Syndr Obes. 2011;4:337-46. [Crossref]  [PubMed] 
  52. Bandodkar AJ, Jia W, Yardımcı C, Wang X, Ramirez J, Wang J. Tattoo-based noninvasive glucose monitoring: a proof-of-concept study. Anal Chem. 2015;87(1):394-8. [Crossref]  [PubMed] 
  53. Bruen D, Delaney C, Florea L, Diamond D. Glucose sensing for diabetes monitoring: recent developments. Sensors (Basel). 2017;17(8):1866. [Crossref]  [PubMed]  [PMC] 
  54. Yu J, Zhang Y, Ye Y, DiSanto R, Sun W, Ranson D, et al. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proc Natl Acad Sci USA. 2015;112(27):8260-5. [Crossref]  [PubMed]  [PMC] 
  55. Veiseh O, Langer R. Diabetes: A smart insulin patch. Nature. 2015;524(7563):39-40. [Crossref]  [PubMed] 
  56. Patients Pending Limited. Timesulin. Available from: (Erişim Tarihi: 15.07.2020) [Link] 
  57. Novolog [Internet]. © 2020 Novo Nordisk. [cited 15.07.2020]. NovoLog® has insulin pens designed to meet your patients' needs. Available from: [Link] 
  58. Companion Medical [Internet]. © 2021 Companion Medical. [cited 15.7.2020]. InPen. Available from: [Link] 
  59. Zhai YK, Zhu WJ, Cai YL, Sun DX, Zhao J. Clinical-and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Medicine (Baltimore). 2014;93(28):e312. [Crossref]  [PubMed]  [PMC] 
  60. Craig J, Patterson V. Introduction to the practice of telemedicine. J Telemed Telecare. 2005;11(1):3-9. [Crossref]  [PubMed] 
  61. Klonoff DC. Telemedicine for diabetes: current and future trends. j diabetes sci technol. 2015;10(1):3-5. [Crossref]  [PubMed]  [PMC] 
  62. Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med. 2011;28(4):455-63. [Crossref]  [PubMed] 
  63. Voluntis [Internet]. ©Voluntis 2020. [cited: 15.7.2020]. Our digital therapeutics: diabetes. Insulia. Available from: [Link] 
  64. Debong F, Mayer H, Kober J. Real-World Assessments of mySugr Mobile Health App. Diabetes Technol Ther. 2019;21(S2):S235-S240. [Crossref]  [PubMed] 
  65. mySugr GmbH. mySugr. Available from: (Erişim Tarihi: 15.7.2020) [Link] 

.: Up To Date

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com